These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 35290756)

  • 41. SARS-CoV-2 immune repertoire in MIS-C and pediatric COVID-19.
    Ravichandran S; Tang J; Grubbs G; Lee Y; Pourhashemi S; Hussaini L; Lapp SA; Jerris RC; Singh V; Chahroudi A; Anderson EJ; Rostad CA; Khurana S
    Nat Immunol; 2021 Nov; 22(11):1452-1464. PubMed ID: 34611361
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rapid decline of neutralizing antibodies is associated with decay of IgM in adults recovered from mild COVID-19.
    Harrington WE; Trakhimets O; Andrade DV; Dambrauskas N; Raappana A; Jiang Y; Houck J; Selman W; Yang A; Vigdorovich V; Yeung W; Haglund M; Wallner J; Oldroyd A; Hardy S; Stewart SWA; Gervassi A; Van Voorhis W; Frenkel L; Sather DN
    Cell Rep Med; 2021 Apr; 2(4):100253. PubMed ID: 33842901
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characteristics and roles of severe acute respiratory syndrome coronavirus 2-specific antibodies in patients with different severities of coronavirus 19.
    Huang Z; Chen H; Xue M; Huang H; Zheng P; Luo W; Liang X; Sun B; Zhong N
    Clin Exp Immunol; 2020 Nov; 202(2):210-219. PubMed ID: 32706417
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serological and viral genetic features of patients with COVID-19 in a selected German patient cohort-correlation with disease characteristics.
    Schmidt J; Berghaus S; Blessing F; Wenzel F; Herbeck H; Blessing J; Schierack P; Rödiger S; Roggenbuck D
    Geroscience; 2021 Oct; 43(5):2249-2264. PubMed ID: 34468954
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improved diagnosis of SARS-CoV-2 by using nucleoprotein and spike protein fragment 2 in quantitative dual ELISA tests.
    De Marco Verissimo C; O'Brien C; López Corrales J; Dorey A; Cwiklinski K; Lalor R; Doyle JM; Field S; Masterson C; Ribes Martinez E; Hughes G; Bergin C; Walshe K; McNicholas B; Laffey JG; Dalton JP; Kerr C; Doyle S
    Epidemiol Infect; 2021 Jun; 149():e140. PubMed ID: 34099081
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SARS-CoV-2 proteome microarray for global profiling of COVID-19 specific IgG and IgM responses.
    Jiang HW; Li Y; Zhang HN; Wang W; Yang X; Qi H; Li H; Men D; Zhou J; Tao SC
    Nat Commun; 2020 Jul; 11(1):3581. PubMed ID: 32665645
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients.
    Varnaitė R; García M; Glans H; Maleki KT; Sandberg JT; Tynell J; Christ W; Lagerqvist N; Asgeirsson H; Ljunggren HG; Ahlén G; Frelin L; Sällberg M; Blom K; Klingström J; Gredmark-Russ S
    J Immunol; 2020 Nov; 205(9):2437-2446. PubMed ID: 32878912
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comprehensive serologic profile and specificity of maternal and neonatal cord blood SARS-CoV-2 antibodies.
    Boelig RC; Chaudhury S; Aghai ZH; Oliver EA; Mancuso F; Berghella V; Bergmann-Leitner ES
    AJOG Glob Rep; 2022 Feb; 2(1):100046. PubMed ID: 34961853
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SARS-CoV-2 antibody responses associate with sex, age and disease severity in previously uninfected people admitted to hospital with COVID-19: An ISARIC4C prospective study.
    Parker E; Thomas J; Roper KJ; Ijaz S; Edwards T; Marchesin F; Katsanovskaja K; Lett L; Jones C; Hardwick HE; Davis C; Vink E; McDonald SE; Moore SC; Dicks S; Jegatheesan K; Cook NJ; Hope J; Cherepanov P; McClure MO; Baillie JK; Openshaw PJM; Turtle L; Ho A; Semple MG; Paxton WA; Tedder RS; Pollakis G;
    Front Immunol; 2023; 14():1146702. PubMed ID: 37056776
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Obtaining a high titer of polyclonal antibodies from rats to the SARS-CoV-2 nucleocapsid protein and its N- and C-terminal domains for diagnostic test development.
    de Almeida MT; Barbosa AP; Bomfim CG; Visnardi AB; Vinces TC; Ceroni A; Durigon EL; Guzzo CR
    J Immunol Methods; 2023 Nov; 522():113558. PubMed ID: 37704125
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-SARS-CoV-2 antibody immunoreactivity profiles during COVID-19 recurrence.
    Gouvea MDPG; Moulaz IR; Gouveia TM; Lança KEM; Lacerda BSP; Thompson BP; Polese J; Lima MD; Ribeiro-Rodrigues R; Mill JG; Valim V
    Rev Soc Bras Med Trop; 2022; 55():e01062022. PubMed ID: 36287469
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [What Is an Antibody Test? Characteristics of Antibodies against SARS-CoV-2 and Their Tests].
    Ishii-Watabe A
    Yakugaku Zasshi; 2022; 142(6):611-618. PubMed ID: 35650081
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-SARS CoV-2 IgG in COVID-19 Patients with Hematological Diseases: A Single-center, Retrospective Study in Japan.
    Fujii T; Hagihara M; Mitamura K; Nakashima S; Ohara S; Uchida T; Inoue M; Okuda M; Yasuhara A; Murakami J; Duong C; Iwatsuki-Horimoto K; Yamayoshi S; Kawaoka Y
    Intern Med; 2022 Jun; 61(11):1681-1686. PubMed ID: 35342138
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunogenic SARS-CoV-2 S and N Protein Peptide and Cytokine Combinations as Biomarkers for Early Prediction of Fatal COVID-19.
    Martynova E; Hamza S; Markelova M; Garanina E; Davidyuk Y; Shakirova V; Kaushal N; Baranwal M; Stott-Marshall RJ; Foster TL; Rizvanov A; Khaiboullina S
    Front Immunol; 2022; 13():830715. PubMed ID: 35386707
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Severe Acute Respiratory Syndrome Coronavirus 2 Nucleocapsid Antigen in Urine of Hospitalized Patients With Coronavirus Disease 2019.
    Veyrenche N; Pisoni A; Debiesse S; Bollore K; Bedin AS; Makinson A; Niel C; Alcocer-Cordellat C; Mondain AM; Le Moing V; Van de Perre P; Tuaillon E
    J Infect Dis; 2022 Sep; 226(5):812-821. PubMed ID: 35230450
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Universal Fluorescent Immunochromatography Assay Based on Quantum Dot Nanoparticles for the Rapid Detection of Specific Antibodies against SARS-CoV-2 Nucleocapsid Protein.
    Li Z; Wang A; Zhou J; Chen Y; Liu H; Liu Y; Zhang Y; Ding P; Zhu X; Liang C; Qi Y; Liu E; Zhang G
    Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682904
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biopanning of specific peptide for SARS-CoV-2 nucleocapsid protein and enzyme-linked immunosorbent assay-based antigen assay.
    Ma P; Liu J; Pang S; Zhou W; Yu H; Wang M; Dong T; Wang Y; Wang Q; Liu A
    Anal Chim Acta; 2023 Jul; 1264():341300. PubMed ID: 37230729
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Elevated Levels of Cytotoxicity, Cytokines, and Anti-SARS-CoV-2 Antibodies in Mild Cases of COVID-19.
    Fernández-Rojas MA; Ávila G; Romero-Valdovinos M; Plett-Torres T; Salazar AM; Sordo M; Chávez-Vargas M; Coeto Ángeles CJ; Cruz-Rivera M; Santiago-Olivares C; Ramírez Hinojosa JP; Maravilla P; Flisser A; Ostrosky-Wegman P; Mendlovic F
    Viral Immunol; 2023 Oct; 36(8):550-561. PubMed ID: 37603294
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunized mice naturally process in silico-derived peptides from the nucleocapsid of SARS-CoV-2.
    Campos-Ruíz MA; Illades-Aguiar B; Del Moral-Hernández O; Romo-Castillo M; Salazar-García M; Espinoza-Rojo M; Vences-Velázquez A; Cortés-Sarabia K; Luna-Pineda VM
    BMC Microbiol; 2023 Oct; 23(1):319. PubMed ID: 37898784
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Towards Control and Oversight of SARS-CoV-2 Diagnosis and Monitoring through Multiplexed Quantitative Electroanalytical Immune Response Biosensors.
    Torrente-Rodríguez RM; Montero-Calle A; San Bartolomé C; Cano O; Vázquez M; Iglesias-Caballero M; Corral-Lugo A; McConnell MJ; Pascal M; Mas V; Pingarrón JM; Barderas R; Campuzano S
    Angew Chem Int Ed Engl; 2022 Jul; 61(28):e202203662. PubMed ID: 35507573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.